May 18, 2023 – Attorney General Miyares joins 39-state bipartisan coalition to protect communities from the dangers of illegal xylazine

Images of the Virginia AG Seal

Office of the Attorney General

Jason S. Miyares
Prosecutor General

202 North 9th Street
Richmond, Virginia 23219
FAX 804-786-1991
Virginia Relay Service

For press inquiries only:
Victoria Lacivita
(804) 588-2021

This email address is being protected from spambots. JavaScript must be enabled to view.

Attorney General Miyares Joins 39-State Bipartisan Coalition to Protect Communities from Danger of Illicit Xylazine

RICHMOND, Virginia – Attorney General Jason Miyales today joined a bipartisan coalition of 39 state attorneys general to pass the Illicit Xylazine Act (HR1839/S.993), which provides important steps to combat widespread illegal use. ) to Congressional leadership. Prevent xylazine trafficking and prevent xylazine-related deaths.

Today’s letter follows a nationwide spike in overdose deaths associated with xylazine, a potent veterinary drug widely mixed with fentanyl and other opioids and readily available online. It is. Over the past few months, several federal agencies, including the US Drug Enforcement Administration (DEA), have issued public warnings about the dangers of xylazine.

“Xylazine will destroy our nation unless Congress takes swift action to combat this new threat and save precious lives.” Attorney General Miyares said.. “Recently, the DEA noted that a kilogram of powdered xylazine can be easily purchased online from Chinese suppliers for as little as $6 to $20. It can provide an inexpensive mechanism for retaining customers who are loyal.”

Xylazine is only approved by the US Food and Drug Administration (FDA) as a veterinary drug used for sedation and pain relief in large animals. In humans, xylazine is known to depress respiration and heart rate, lower blood pressure, and can lead to unconsciousness, necrosis, and even death. Because xylazine is not an opioid, existing drugs such as naloxone do not reverse the effects of drugs when used with opioids.

According to the DEA, between 2020 and 2021, xylazine-related overdose deaths will rise dramatically across the country, rising 1,127 percent in the South, 750 percent in the West, and 516 percent in the Middle East. 103% in the Northeast region. Additionally, about 23 percent of fentanyl powders and about 7 percent of fentanyl tablets seized by the DEA in 2022 contained xylazine. To prevent the spread of xylazine and protect our communities, Attorney General Miyares and the Coalition emphasized the importance of measures outlined in the Illegal Xylazine Countermeasures Act, including:

  • Classify the illegal use of xylazine as a Schedule III drug under the Federal Controlled Substances Act.
  • Allows the DEA to track the manufacture and sale of xylazine and ensure that it is not diverted.
  • Acting through the DEA and working with the FDA Commissioner to request the U.S. Attorney General to submit a report to Congress detailing the prevalence of xylazine, the risks, and recommendations on how to control the illegal use of xylazine do.and
  • All salts, isomers and other forms of xylazine should be covered when restricting illegal drug use.

Sending today’s letter with Attorney General Miyares to Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Hawaii, and Illinois. Attorneys General of the states, Indiana, Kentucky, Louisiana, Maryland and Michigan. , Minnesota, Missouri, Nevada, New Hampshire, New Mexico, New York, North Carolina, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Washington, West Virginia, Wisconsin.


Source link

Leave a Reply

Your email address will not be published. Required fields are marked *